Abstract
Intravesical Bacillus Calmette–Guerin (BCG) immunotherapy is a proven, effective treatment for intermediate- and high-risk non-muscle-invasive bladder cancer. Minor side effects are common and expected but systemic effects can occur in < 5% of treated patients. We present a rare case of a 49-year-old male that presented with fever and chills after 3 weeks of intravesical BCG therapy post transurethral resection of bladder tumor. New renal lesions were present on contrast-enhanced computed tomography scan which was histologically proven to be necrotizing renal granulomatosis.
Document Type
Article
Publication Date
4-18-2018
Digital Object Identifier (DOI)
https://doi.org/10.4103/2156-7514.230280
Repository Citation
Tran-Harding, Karen; Nair, Rashmi T.; and Ganesh, Halemane S., "Renal Granulomatosis Post Intravesical Bacillus Calmette-Guerin Therapy for Non-Muscle-Invasive Bladder Cancer" (2018). Radiology Faculty Publications. 14.
https://uknowledge.uky.edu/radiology_facpub/14
Included in
Bioimaging and Biomedical Optics Commons, Diagnosis Commons, Oncology Commons, Radiology Commons, Urology Commons
Notes/Citation Information
Published in Journal of Clinical Imaging Science, v. 8, 18, p. 1-4.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.